Benchmark, a global aquaculture, genetics, health and nutrition firm, more than doubled its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) in the third quarter of the year, the result of higher revenues, operational improvements and continuous cost control.
The company posted adjusted EBITDA of £4.4 million (€5.1 million/$6 million) in the quarter compared with £2.1 million (€2.5 million/$2.9 million) in the same period a year ago, while the group’s revenues were up 17 percent at £28.3 million (€33.1
